Rapports sexuels anaux et maladies inflammatoires chroniques intestinales : ce que tout gastroentérologue doit savoir
Volume 25, numéro 9, Novembre 2018
[1]Bajos N, Bozon M. (dir.). Enquête sur la sexualité en France. Pratiques, genre et santé. Paris : La Découverte, 2008.
[2]Martin T., Smukalla S.M., Kane S. Receptive Anal Intercourse in Patients with Inflammatory Bowel Disease : A Clinical Review. Inflamm Bowel Dis. 2017;23:1285-1292.
[3]Wisniewski A., Fléjou J.-F., Siproudhis L. Anal Neoplasia in Inflammatory Bowel Disease: Classification Proposal, Epidemiology, Carcinogenesis, and Risk Management Perspectives. J Crohns Colitis. 2017;11:1011-1018.
[4]Nelson V.M., Benson A.B. Epidemiology of Anal Canal Cancer. Surg Oncol Clin N Am. 2017;26:9-15.
[5]Roberts J.R., Siekas L.L., Kaz A.M. Anal intraepithelial neoplasia : A review of diagnosis and management. World J Gastrointest Oncol. 2017;9:50-61.
[6]Beaugerie L, Carrat F, Nahon S, et al. High risk of anal and rectal cancer in patients with anal and/or perianal Crohn's disease. Clin Gastroenterol Hepatol 2018 ; 16(6) : 892-899.
[7]Slesser A.P., Bhangu A., Bower M. A systematic review of anal squamous cell carcinoma in inflammatory bowel disease. Surg Oncol. 2013;22:230-237.
[8]Ruel J., Ko H.M., Roda G. Anal Neoplasia in Inflammatory Bowel Disease Is Associated With HPV and Perianal Disease. Clin Transl Gastroenterol. 2016;7:e148.
[9]Shah S.B., Pickham D., Araya H. Prevalence of Anal Dysplasia in Patients With Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2015;13:1955-1961.e1.
[10]van der Have M., van der Aalst K.S., Kaptein A.A. Determinants of health-related quality of life in Crohn's disease : a systematic review and meta-analysis. J Crohns Colitis. 2014;8:93-106.
[11]Riss S., Schwameis K., Mittlböck M. Sexual function and quality of life after surgical treatment for anal fistulas in Crohn's disease. Tech Coloproctology. 2013;17:89-94.
[12]Noor S.W., Rosser B.R.S. Enema use among men who have sex with men: A behavioral epidemiologic study with implications for HIV/STI prevention. Arch Sex Behav. 2014;43:755-769.
[13]Fuchs E.J., Lee L.A., Torbenson M.S. Hyperosmolar sexual lubricant causes epithelial damage in the distal colon : potential implication for HIV transmission. J Infect Dis. 2007;195:703-710.
[14]Dezzutti C.S., Brown E.R., Moncla B. Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity. PloS One. 2012;7:e48328.
[15]Lindsey K., DeCristofaro C., James J. Anal Pap smears: Should we be doing them? J Am Acad Nurse Pract. 2009;21:437-443.
[16]Cranston RD, Regueiro M, Hashash J, et al. A Pilot Study of the Prevalence of Anal Human Papillomavirus and Dysplasia in a Cohort of Patients With IBD. Dis Colon Rectum 2017 ; 60 : 1307-13.
[17]Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011 ; 365 : 1576-85.
[18]Castle P.E., Maza M. Prophylactic HPV vaccination: Past, present, and future. Epidemiol Infect. 2016;144:449-468.
[19]Ruche G.L., Strat Y.L., Fromage M. Incidence of gonococcal and chlamydial infections and coverage of two laboratory surveillance networks, France, 2012. Eurosurveillance. 2015;20:21205.